{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:01:12Z","timestamp":1790762472579,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal de Mycologie M\u00e9dicale"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.mycmed.2012.04.004","type":"journal-article","created":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T12:22:37Z","timestamp":1341318157000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs"],"prefix":"10.1016","volume":"22","author":[{"given":"T.","family":"No\u00ebl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mycmed.2012.04.004_bib0005","doi-asserted-by":"crossref","first-page":"e21239","DOI":"10.1371\/journal.pone.0021239","article-title":"Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance","volume":"6","author":"Alvarez-Rueda","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/02681219880000701","article-title":"In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae","volume":"36","author":"Barchiesi","year":"1998","journal-title":"Med Mycol"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00438-011-0650-z","article-title":"An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicans","volume":"286","author":"Bruzual","year":"2011","journal-title":"Mol Genet Genomics"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0020","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0025","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0030","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/EC.00069-09","article-title":"Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system","volume":"8","author":"Coste","year":"2009","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","article-title":"A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate","volume":"7","author":"Dunkel","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1097-0061(199701)13:1<43::AID-YEA56>3.0.CO;2-J","article-title":"Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames with the major facilitator superfamily","volume":"13","author":"Goffeau","year":"1997","journal-title":"Yeast"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0045","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1073\/pnas.1117280109","article-title":"Amphotericin primarily kills yeast by simply binding ergosterol","volume":"109","author":"Gray","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0055","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1128\/AAC.37.9.1962","article-title":"Fluconazole resistance in Candida glabrata","volume":"37","author":"Hitchcock","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2958.2006.05357.x","article-title":"Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2","volume":"62","author":"Holmes","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0065","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.00995-10","article-title":"An A643V amino acid substitution in Upc2p contributes to azole resistance in well-characterized clinical isolates of Candida albicans","volume":"55","author":"Hoot","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0070","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1006\/bbrc.1995.1272","article-title":"Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta, 6 alpha-diol","volume":"207","author":"Kelly","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0075","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1074\/jbc.272.9.5682","article-title":"The mutation T315A in Candida albicans sterol 14alpha-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity","volume":"272","author":"Lamb","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0080","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","article-title":"Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes","volume":"49","author":"MacPherson","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0085","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.41.10.2229","article-title":"Molecular biological characterization of an azole-resistant Candida glabrata isolate","volume":"41","author":"Marichal","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0090","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1099\/00221287-145-10-2701","article-title":"Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans","volume":"145","author":"Marichal","year":"1999","journal-title":"Microbiology"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0095","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0100","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschh\u00e4user","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0105","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/JCM.01952-07","article-title":"Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.: results from a global antifungal surveillance program","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0110","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","article-title":"Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors","volume":"98","author":"Podust","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00352101","article-title":"Molecular cloning and characterization of a novel gene of Candida albicans CDR1, conferring multiple resistance to drugs and antifungals","volume":"27","author":"Prasad","year":"1995","journal-title":"Curr Genet"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.diagmicrobio.2006.04.019","article-title":"Up-regulation of ERG11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication?","volume":"57","author":"Ribeiro","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0125","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1099\/00221287-143-2-405","article-title":"Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene","volume":"143","author":"Sanglard","year":"1997","journal-title":"Microbiology"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0130","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/AAC.01343-10","article-title":"Regulation of efflux pump expression and drug resistance by the transcription factors Mrr1 Upc2, and Cap1 in Candida albicans","volume":"55","author":"Schubert","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1126\/science.1128242","article-title":"Aneuploidy and isochromosome formation in drug-resistant Candida albicans","volume":"313","author":"Selmecki","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0140","doi-asserted-by":"crossref","first-page":"e1000705","DOI":"10.1371\/journal.pgen.1000705","article-title":"Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance","volume":"5","author":"Selmecki","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0145","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/EC.00060-10","article-title":"Genomic plasticity of the human fungal pathogen Candida albicans","volume":"9","author":"Selmecki","year":"2010","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0150","doi-asserted-by":"crossref","first-page":"12445","DOI":"10.1074\/jbc.271.21.12445","article-title":"The mechanism of the acyl-carbon bond cleavage reaction catalyzed by recombinant sterol 14 alpha-demethylase of Candida albicans (other names are: lanosterol 14 alpha-demethylase P-45014DM, and CYP51)","volume":"271","author":"Shyadehi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0155","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/EC.3.6.1391-1397.2004","article-title":"Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism","volume":"3","author":"Silver","year":"2004","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/yea.818","article-title":"ABC transporters Cdr1p Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators","volume":"19","author":"Smriti","year":"2002","journal-title":"Yeast"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0165","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/S0021-9258(18)46051-6","article-title":"Multiple regulatory elements control expression of the gene encoding the Saccharomyces cerevisiae cytochrome P450, lanosterol 14 alpha-demethylase (ERG11)","volume":"267","author":"Turi","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0170","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.11.2.382","article-title":"Clinical, cellular, and molecular factors that contribute to antifungal drug resistance","volume":"11","author":"White","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1046\/j.1365-2958.2000.01899.x","article-title":"Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates","volume":"36","author":"Wirsching","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.mycmed.2012.04.004_bib0185","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1128\/AAC.48.2.568-574.2004","article-title":"Three-dimensional models of wild-type and mutated forms of cytochrome P450 14alpha-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding","volume":"48","author":"Xiao","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal de Mycologie M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523312000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523312000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:15:27Z","timestamp":1761110127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523312000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1156523312000406"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2012.04.004","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The cellular and molecular defense mechanisms of the Candida yeasts against azole antifungal drugs","name":"articletitle","label":"Article Title"},{"value":"Journal de Mycologie M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2012.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}